Advertisement
Screener

Kiniksa Pharmaceuticals International, plc (KNSA) Graph

KNSA Revenue Flow

Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.

  • 2026-03-31: Revenue $214.27M; Cost of revenue $20.80M; Research and development $27.48M; Selling, general and administrative $61.15M.
  • 2025-12-31: Revenue $202.13M*; Cost of revenue $20.95M*; Research and development $34.61M*; Selling, general and administrative $56.77M*.
  • 2025-09-30: Revenue $180.85M; Cost of revenue $20.26M; Research and development $24.17M; Selling, general and administrative $49.10M.
  • 2025-06-30: Revenue $156.80M; Cost of revenue $18.60M; Research and development $18.75M; Selling, general and administrative $46.86M.

Product or service

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

KNSA revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Product$243.60MRevenue$243.60MCost of revenue$23.57MOperating income$27.19MResearch & development$40.90MSelling, general& administrative$63.87MPre-tax income$31.14MIncome tax$5.71MNet income$25.43M

Segment

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

KNSA revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Pharmaceutical Segment$243.60MRevenue$243.60MCost of revenue$23.57MOperating income$27.19MResearch & development$40.90MSelling, general& administrative$63.87MPre-tax income$31.14MIncome tax$5.71MNet income$25.43M

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2026-03-31$214.27M$20.80M$27.48M$61.15M(m)$10.09M$22.59M
2025-12-31$202.13M*$20.95M*$34.61M*$56.77M*(m)$9.07M*$14.20M*
2025-09-30$180.85M$20.26M$24.17M$49.10M(m)$8.72M$18.43M
2025-06-30$156.80M$18.60M$18.75M$46.86M(m)$5.04M$17.83M
2025-03-31$137.78M$17.87M$19.32M$43.53M(m)$7.03M$8.54M
2024-09-30$112.21M$20.11M$26.06M$46.40M(m)$5.49M-$12.69M
2024-06-30$108.63M$12.32M$24.02M$42.40M(m)$6.21M-$3.91M
2024-03-31$79.86M$10.58M$26.33M$38.68M(m)$3.43M-$17.70M
2023-09-30$67.05M$9.09M$17.11M$34.47M(m)$5.36M-$13.86M
2023-06-30$71.47M$7.70M$23.77M$29.18M(m)-$16.21M$14.97M
2023-03-31$48.34M$7.04M$15.17M$29.05M(m)$2.91M-$12.27M
2022-09-30$99.14M$6.94M$16.48M$24.68M(m)-$177.36M$224.09M
2022-06-30$26.97M$5.03M$13.80M$23.84M(m)$716.00K-$19.98M
2022-03-31$32.19M(m)$20.82M$22.22M(m)$1.93M-$25.21M
2021-12-31(m)$3.87M*(m)(m)(m)(m)(m)
2021-09-30$12.10M$2.77M$19.24M$20.76M(m)-$118.00K-$30.54M
2021-06-30$7.70M$2.47M$23.95M$21.85M(m)$1.01M-$41.56M
2021-03-31(m)(m)$28.68M$20.60M$49.28M$210.00K-$49.48M
2020-12-31(m)(m)(m)(m)$52.90M*(m)(m)
2020-09-30(m)(m)$31.42M$11.80M$43.22M$667.00K-$43.84M
2020-06-30(m)(m)$22.32M$9.54M$31.86M$5.88M-$37.47M
2020-03-31(m)(m)$20.90M(m)$29.39M-$2.18M-$26.42M
2019-09-30(m)(m)$22.01M(m)$30.45M-$2.00M-$27.06M
2019-06-30(m)(m)$30.85M(m)$39.29M-$374.00K-$37.19M
2019-03-31(m)(m)$59.25M(m)$67.65M-$17.00K-$65.82M
2018-09-30(m)(m)$20.64M(m)$26.16M-$131.00K-$24.41M
2018-06-30(m)(m)$17.20M(m)$21.53M-$202.00K-$20.26M
2018-03-31(m)(m)$12.63M(m)$16.34M-$53.00K-$15.98M
2017-09-30(m)(m)$14.01M(m)$16.25M-$51.00K-$16.03M
2017-06-30(m)(m)$9.27M(m)$11.39M-$36.00K-$11.20M

Revenue and expense 6 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2025-06-30$294.58M$36.47M$38.08M$90.39M(m)$12.07M$26.37M
2024-06-30$188.49M$22.91M$50.35M$81.08M(m)$9.64M-$21.61M
2023-06-30$119.82M$14.73M$38.94M$58.22M(m)-$13.30M$2.70M
2022-06-30$59.16M$9.25M$34.62M$46.06M(m)$2.64M-$45.19M
2021-06-30$7.70M$2.47M$52.63M$42.45M(m)$1.22M-$91.05M
2020-06-30(m)(m)$43.23M$18.02M$61.25M$3.70M-$63.89M
2019-06-30(m)(m)$90.10M(m)$106.94M-$391.00K-$103.01M
2018-06-30(m)(m)$29.83M(m)$37.87M-$255.00K-$36.24M
2017-06-30(m)(m)$12.42M(m)$16.44M-$70.00K-$16.14M

Revenue and expense 9 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2025-09-30$475.44M$56.73M$62.24M$139.50M(m)$20.79M$44.81M
2024-09-30$300.70M$43.01M$76.41M$127.48M(m)$15.13M-$34.30M
2023-09-30$186.86M$23.82M$56.05M$92.69M(m)-$7.95M-$11.15M
2022-09-30$158.30M$16.18M$51.10M$70.74M(m)-$174.72M$178.90M
2021-09-30$19.80M$5.23M$71.86M$63.21M(m)$1.11M-$121.59M
2020-09-30(m)(m)$74.64M$29.82M$104.47M$4.36M-$107.72M
2019-09-30(m)(m)$112.11M(m)$137.38M-$2.39M-$130.07M
2018-09-30(m)(m)$50.48M(m)$64.03M-$386.00K-$60.65M
2017-09-30(m)(m)$26.43M(m)$32.69M-$121.00K-$32.17M

Revenue and expense 12 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2025-12-31$677.56M$77.67M$96.85M$196.27M(m)$29.86M$59.01M
2024-12-31$423.24M$60.91M$111.62M$168.01M(m)$7.04M-$43.19M
2023-12-31$270.26M$33.41M$76.10M$129.43M(m)-$30.74M$14.08M
2022-12-31$220.18M$22.89M$65.49M$97.95M(m)-$172.34M$183.36M
2021-12-31$38.54M$9.10M$99.30M$85.95M(m)$1.39M-$157.92M
2020-12-31(m)(m)$112.04M$45.32M$157.36M$5.15M-$161.38M
2019-12-31(m)(m)$135.00M$34.96M$169.96M-$2.05M-$161.87M
2018-12-31(m)(m)$86.60M(m)$108.16M-$214.00K-$103.23M
2017-12-31(m)(m)$56.36M(m)$65.40M$2.00K-$64.87M